Analytical System with advanced, integrated multi-attribute characterization platform

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

FDA OFFICE OF ACQ GRANT SVCS

Contract Value

Not provided

Codes & Classification
Solicitation Number

75F40126Q134650

NAICS

334516 - Analytical Laboratory Instrument Manufacturing

Classification Code

6630

Additional Details
Set Aside

None

Place of Performance

Silver Spring, Maryland, UNITED STATES

SourceSAM
Documents2
The Food and Drug Administration (FDA), operating under the Department of Health and Human Services, has issued a combined synopsis/solicitation for the procurement of an Analytical System featuring an advanced, integrated multi-attribute characterization platform. This opportunity, identified by procurement number 75F40126Q134650, is currently active and seeks to address the agency’s need for sophisticated laboratory instrumentation to support its mission-critical analytical and regulatory functions. The primary objective of this procurement is to acquire a state-of-the-art analytical system capable of comprehensive, multi-attribute characterization. Such a platform is expected to enhance the FDA’s laboratory capabilities, enabling precise and efficient analysis of complex samples. The system will likely be utilized for a range of applications, including but not limited to, quality control, product characterization, and regulatory compliance testing. The intended outcome is to bolster the FDA’s ability to ensure the safety, efficacy, and quality of products under its purview. Key requirements for this solicitation include the provision of an integrated analytical system that combines advanced technologies for multi-attribute analysis. While specific technical specifications are detailed in the attached solicitation documents, prospective contractors should anticipate the need for a robust, reliable, and user-friendly platform that meets the rigorous standards of a federal regulatory laboratory. Deliverables are expected to encompass the analytical instrument itself, associated software, installation, and potentially training and ongoing support services. The place of performance for this contract is Silver Spring, Maryland, reflecting the location of the FDA’s relevant laboratory facilities. The procurement falls under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing), with a corresponding Product Service Code of 6630, indicating a focus on chemical analysis instruments. This opportunity is managed by the FDA Office of Acquisition and Grant Services. Interested parties should direct all inquiries to the primary point of contact, Nick Sartain, who can be reached via email at [email protected] or by phone at 301-796-1988. The procurement is being conducted as a combined synopsis/solicitation, streamlining the process for both the agency and potential offerors. Contractors should review the attached amendment and solicitation documents for comprehensive requirements and submission instructions. The notice does not specify any set-aside requirements or special considerations; therefore, all qualified vendors within the relevant NAICS classification are encouraged to respond. Responses are due by August 26, 2026, at 18:08. Interested contractors should ensure timely submission of proposals in accordance with the instructions provided in the solicitation documents. For further details and to access the attachments, contractors may refer to the official notice on SAM.gov at https://sam.gov/opp/ce81fd29707a445abf50509ca6388d44/view. This procurement represents a significant opportunity for manufacturers and suppliers of advanced analytical laboratory systems to support the FDA’s critical public health mission through the provision of cutting-edge instrumentation and related services.